Recombinant DNA (rDNA) technology involves joining together DNA molecules from two different species. The recombinant DNA is inserted into a host organism to produce new genetic combinations. This is achieved using restriction enzymes to cut DNA at specific sites and DNA ligase to join the fragments, often incorporating the desired gene into a plasmid vector for cloning.
Recombinant DNA (rDNA)
- Stanley Norman Cohen
- Herbert Boyer
Recombinant DNA technology, also known as genetic engineering, is the process of creating artificial DNA by combining genetic material from different sources. This technology fundamentally changed biology and medicine by allowing scientists to directly manipulate the genetic code of organisms. The core procedure involves several key steps. First, a gene of interest is identified and isolated from a source organism’s DNA. This is often done using restriction enzymes, which are proteins that act like molecular scissors, cutting DNA at specific recognition sequences. Second, a vector, which is a DNA molecule used to carry the foreign genetic material into another cell, is chosen. Bacterial plasmids—small, circular DNA molecules separate from the bacterial chromosome—are the most common vectors. The same restriction enzyme used to cut out the gene is used to cut open the plasmid vector. This creates compatible ‘sticky ends’ on both the gene and the plasmid. Third, the isolated gene is inserted into the plasmid. The sticky ends of the gene anneal with the complementary sticky ends of the plasmid, and the enzyme DNA ligase is added to permanently join them by forming phosphodiester bonds. The resulting molecule is a recombinant plasmid containing the new gene. Finally, this recombinant vector is introduced into a host organism, typically a bacterium like *E. coli*, through a process called transformation. As the host cells multiply, they replicate the recombinant plasmid along with their own DNA, creating many copies of the inserted gene. The host cells can also transcribe and translate the foreign gene to produce the desired protein, such as human insulin produced in bacteria.
Typ
Unterbrechung
Verwendung
Vorläufersubstanzen
- discovery of DNA as genetic material
- elucidation of the DNA double helix structure
- discovery of plasmids in bacteria
- discovery and characterization of restriction enzymes by Werner Arber, Daniel Nathans, and Hamilton Smith
- discovery of DNA ligase
Anwendungen
- production of synthetic human insulin for diabetics
- creation of genetically modified organisms (GMOs)
- production of vaccines (e.g., hepatitis B vaccine)
- gene therapy
- production of clotting factors for hemophilia
Patente:
- US4237224
Mögliche Innovationsideen
!Professionals (100% free) Mitgliedschaft erforderlich
Sie müssen ein Professionals (100% free) Mitglied sein, um auf diesen Inhalt zugreifen zu können.
VERFÜGBAR FÜR NEUE HERAUSFORDERUNGEN
Maschinenbauingenieur, Projekt-, Verfahrenstechnik- oder F&E-Manager
Kurzfristig für eine neue Herausforderung verfügbar.
Kontaktieren Sie mich auf LinkedIn
Integration von Kunststoff-Metall-Elektronik, Design-to-Cost, GMP, Ergonomie, Geräte und Verbrauchsmaterialien in mittleren bis hohen Stückzahlen, Lean Manufacturing, regulierte Branchen, CE und FDA, CAD, Solidworks, Lean Sigma Black Belt, medizinische ISO 13485
Wir suchen einen neuen Sponsor
Ihr Unternehmen oder Ihre Institution beschäftigt sich mit Technik, Wissenschaft oder Forschung?
> Senden Sie uns eine Nachricht <
Erhalten Sie alle neuen Artikel
Kostenlos, kein Spam, E-Mail wird nicht verteilt oder weiterverkauft
oder Sie können eine kostenlose Vollmitgliedschaft erwerben, um auf alle eingeschränkten Inhalte zuzugreifen >Hier<
Verwandte Erfindungen, Innovationen und technische Prinzipien